Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Pharmacare Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 53.59B | 12x | -2.04 | ZAC 12,022 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
Life Healthcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 20.43B | 10.3x | 0.01 | ZAC 1,434 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.7% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 16.16B | 12.2x | ZAC 9,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 16.16B | 12.2x | 0.72 | ZAC 1,343 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.6% Upside | Upgrade to Pro+ | |
Adcock Ingram Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 7.16B | 9.5x | -1.06 | ZAC 4,876 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.6% Upside | Upgrade to Pro+ | |
Ascendis Health Ltd | Johannesburg | Healthcare | Pharmaceuticals | ZAR 500.60M | 28.3x | 0.18 | ZAC 80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cilo Cybin Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 284.07M | 253.5x | ZAC 400 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |